Skip to main content

ADVERTISEMENT

Drug-eluting stents

Costa preview
Author Interview
04/04/2024

J. Ribamar Costa, Jr, MD, PhD

J. Ribamar Costa, Jr, MD, PhD
Dr Deepak L. Bhatt catches up with Dr J. Ribamar Costa about his Editor’s 2023 Top 10 article, “Serial Assessment of Coronary Artery Healing of a Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months by Optical Coherence Tomography...
Dr Deepak L. Bhatt catches up with Dr J. Ribamar Costa about his Editor’s 2023 Top 10 article, “Serial Assessment of Coronary Artery Healing of a Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months by Optical Coherence Tomography...
Dr Deepak L. Bhatt catches up...
04/04/2024
Journal of Invasive Cardiology
Original Contribution
05/01/2023

Guilherme Barreto Gameiro Silva, MD1;  Rafael A. Meneguz-Moreno, MD, PhD1,2; Ricardo Costa, MD, PhD1;  Daniel Chamié, MD, PhD1;  George Dangas, MD, PhD3;  André Manica, MD, PhD4;  Jose Airton Arruda, MD, PhD5;  Amanda G.M.R. Sousa, MD, PhD1;  Fausto Feres, MD, PhD1;  J. Ribamar Costa, Jr, MD, PhD1

Guilherme Barreto Gameiro Silva, MD1;...
In this study, the authors assessed the vessel-healing pattern of the sirolimus-eluting Inspiron DES using serial optical coherence tomography, assuming that this thin-strut, biodegradable-polymer DES promotes a faster healing.
In this study, the authors assessed the vessel-healing pattern of the sirolimus-eluting Inspiron DES using serial optical coherence tomography, assuming that this thin-strut, biodegradable-polymer DES promotes a faster healing.
In this study, the authors...
05/01/2023
Journal of Invasive Cardiology
Interview
01/19/2023

Andrea Kahlberg, MD

Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy

Andrea Kahlberg, MD Vita-Salute Univ...
VDM speaks with Dr. Andrea Kahlberg to discuss the 2-year results of the ILLUMINA study.
VDM speaks with Dr. Andrea Kahlberg to discuss the 2-year results of the ILLUMINA study.
VDM speaks with Dr. Andrea...
01/19/2023
Vascular Disease Management
Original Contribution
11/01/2022

Annemieke C. Ziedses des Plantes, BSc;  Tara Neleman, BSc;
Maria N. Tovar Forero, MD;  Leon Visser, BSc;  Alessandra Scoccia, MD;
Frederik T.W. Groenland, MD;  Jurgen M.R. Ligthart, RT;  Eric Boersma, PhD; Rutger-Jan Nuis, MD, PhD;  Wijnand K. den Dekker, MD, PhD;
Jeroen Wilschut, MD;  Roberto Diletti, MD, PhD;  Felix Zijlstra, MD, PhD;
Nicolas M. Van Mieghem, MD, PhD;  Joost Daemen, MD, PhD

Annemieke C. Ziedses des Plantes, BSc...
Thinner stent struts might lead to a higher risk of recoil and subsequently a smaller minimal stent area (MSA), which is known to be the strongest predictor of stent failure. We compared procedural performance between an ultrathin-strut...
Thinner stent struts might lead to a higher risk of recoil and subsequently a smaller minimal stent area (MSA), which is known to be the strongest predictor of stent failure. We compared procedural performance between an ultrathin-strut...
Thinner stent struts might lead...
11/01/2022
Journal of Invasive Cardiology
Original Contribution
07/22/2022

Uram Jin, MD1*;  Kyoung-Woo Seo, MD1*;  Hyoung-Mo Yang, MD, PhD1;  Hong-Seok Lim, MD, PhD1;  Byoung-Joo Choi, MD1;  So-Yeon Choi, MD, PhD1;  Joon-Han Shin, MD1;  Seung-Jea Tahk, MD, PhD1;  Sang-Yong Yoo, MD1;  Seung Woon Rha, MD, PhD3;  Woo-Young Chung, MD, PhD4;  Chi-Hoon Kim, MD5;  Ki-Bum Won, MD6;  Wook Bum Pyun, MD, PhD7;  Jae Sik Jang, MD, PhD8;  Sung Yun Lee, MD9;  Young Joon Hong, MD10;  Moo Hyun Kim, MD, PhD11;  Soon Jun Hong, MD12;  Yun-Seok Choi, MD13;  Hee-Yeol Kim, MD14;  Rak Kyeong Choi, MD, PhD15;  Woong Chol Kang, MD, PhD16;  Eun Joo Cho, MD, PhD13;  Myeong-Ho Yoon, MD, PhD1

Uram Jin, MD1*;  Kyoung-Woo Seo, MD1*...
This study examined the efficacy and safety of 3- versus 6-month DAPT in patients implanted with Coroflex ISAR polymer-free DESs.
This study examined the efficacy and safety of 3- versus 6-month DAPT in patients implanted with Coroflex ISAR polymer-free DESs.
This study examined the efficacy...
07/22/2022
Journal of Invasive Cardiology
Original Contribution
12/01/2021

Ahmed Mahmoud El Amrawy, MD; Mohamed Ibrahim Loutfi, MD; Salah Mohamed El Tahan, MD; Sherif Wagdy Ayad, MD

Ahmed Mahmoud El Amrawy, MD; Mohamed ...
The study goal was to assess the feasibility and short-term clinical outcomes of implanting 48 mm drug-eluting stents (DESs) for the treatment of long lesions in patients with coronary artery disease (CAD).
The study goal was to assess the feasibility and short-term clinical outcomes of implanting 48 mm drug-eluting stents (DESs) for the treatment of long lesions in patients with coronary artery disease (CAD).
The study goal was to assess the...
12/01/2021
Journal of Invasive Cardiology
Commentary
01/14/2020

Michael Patel, MD1; Robert Beasley, MD, FSIR, FSCAI2

 

1Department of Interventional Radiology, Mount Sinai Medical Center, Miami Beach, Florida; 2Robert Beasley, Section Chief, Vascular/ Interventional Radiology, Mount Sinai Medical Center, Miami Beach, Florida

Michael Patel, MD1; Robert Beasley, M...
Michael Patel, MD, and Robert Beasley, MD discuss drug-eluting stents and drug-coated balloons.
Michael Patel, MD, and Robert Beasley, MD discuss drug-eluting stents and drug-coated balloons.
Michael Patel, MD, and Robert...
01/14/2020
Vascular Disease Management
Two-Year Results of IMPERIAL: First-Ever Randomized Study of Eluvia and Zilver PTX in  Femoropopliteal Artery Lesions
Calcium Corner
01/01/2020

An interview with IMPERIAL trial co-principal investigator William A. Gray, MD, FACC, FSCAI, System Chief, Division of Cardiovascular Disease; President, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania.

An interview with IMPERIAL trial co-p...
The Eluvia stent utilizes a drug-polymer combination that provides a sustained release of paclitaxel over one year.
The Eluvia stent utilizes a drug-polymer combination that provides a sustained release of paclitaxel over one year.
The Eluvia stent utilizes a...
01/01/2020
Cath Lab Digest
FDA Panel
06/27/2019

Konstantinos Katsanos, MSc, MD, PhD, EBIR

 

Assistant Professor, Interventional Radiology, School of Medicine, Patras University Hospital, Patras, Greece

Konstantinos Katsanos, MSc, MD, PhD, ...
VDM talks with Konstantinos Katsanos, MSc, MD, PhD, EBIR, Assistant Professor, Interventional Radiology, School of Medicine, Patras University Hospital, Patras, Greece.
VDM talks with Konstantinos Katsanos, MSc, MD, PhD, EBIR, Assistant Professor, Interventional Radiology, School of Medicine, Patras University Hospital, Patras, Greece.
VDM talks with Konstantinos...
06/27/2019
Vascular Disease Management
Clinical and Industry News
03/06/2019
BIO-RESORT RCT Three-Year Data Analysis Shows a Consistent Trend Towards Lower Target Vessel Failure Rates for Orsiro Compared to Resolute Integrity and Synergy Washington, D.C. and BUELACH, Switzerland, March 6, 2019 – Three-year outcome...
BIO-RESORT RCT Three-Year Data Analysis Shows a Consistent Trend Towards Lower Target Vessel Failure Rates for Orsiro Compared to Resolute Integrity and Synergy Washington, D.C. and BUELACH, Switzerland, March 6, 2019 – Three-year outcome...
BIO-RESORT RCT Three-Year Data...
03/06/2019
Cath Lab Digest